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Abstract: Sodium selenate is an important nutraceutical/pharmaceutical compound used for the prevention and treatment of 
cancer, diabetes, inflammatory diseases, etc. The objective of the current study was to investigate the impact of The Trivedi 
Effect® - Energy of Consciousness Healing Treatment (Biofield Energy Healing treatment) on physical, structural, thermal, and 
behavioral properties of sodium selenate using PXRD, PSD, FT-IR, UV-vis, TGA, and DSC analysis. Sodium selenate was 
divided into two parts – one part was control, while another part was treated with The Trivedi Effect® remotely by seven 
renowned Biofield Energy Healers and defined as The Trivedi Effect® Treated sample. The PXRD analysis showed a 
significant alteration of the crystallite size of the treated sample in the range of -34.41% to 33.27% compared to the control 
sample. However, the average crystallite size of the treated sample was significantly decreased by 7.85% compared with the 
control sample. The particle size of the treated sample at d10, d50, and d90 values were significantly reduced by 4.72%, 8.40%, 
and 32.33%, respectively compared with the control sample. Consequently, the surface area of the treated sample was 
significantly increased by 6.25% compared to the control sample. The control and treated FT-IR spectra indicated the presence 
of sharp and strong absorption bands at 886 cm-1 and 887 cm-1, respectively due to the Se=O stretching. The UV-vis 
spectroscopic analysis displayed that the wavelength for the maximum absorbance of the control and treated samples were at 
204.6 and 204.9 nm, respectively. TGA analysis revealed that the total weight loss of the treated sample was reduced 
significantly by 5.64% compared with the control sample. The DSC analysis showed that the treated sample (94.63°C) had 
very close vaporization temperature than the control sample (94.97°C). But, the latent heat of vaporization was increased 
significantly in the treated sample by 7.06% compared to the control sample. Thus, The Trivedi Effect® - Energy of 
Consciousness Healing Treatment might lead to generate a new polymorphic form of sodium selenate, which would be more 
soluble, bioavailable, and thermally stable compared with the untreated sample. The Trivedi Effect® treated sodium selenate 
would be very useful to design better nutraceutical/pharmaceutical formulations that might offer better therapeutic response 
against inflammatory diseases, immunological disorders, stress, aging, infectious diseases, cancer, diabetes, heart diseases, 
Alzheimer’s disease, etc. 
Keywords: Sodium Selenate, The Trivedi Effect®, Consciousness Energy Healing Treatment, PXRD, Particle Size,  
Surface Area, TGA, DSC 
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1. Introduction 
Selenium (Se) is an essential trace nutrient in the human 
body. It plays an important role in various biological 
functions such as catalytic effect on the reaction of 
intermediate metabolism and inhibition of the toxic effect of 
heavy metals. Selenium is present in the active site of 
enzymes like glutathione peroxidase and also in around 30 
proteins as selenocysteine. It is a potent antioxidant and is 
involved in the cellular defense against free radicals [1, 2]. 
Hence, deficiency of selenium produces several disorders 
such as cancer, heart diseases, viral diseases, diabetes, 
infectious diseases, degenerative ailments, etc. As there is a 
very restricted range between essentiality and toxicity, a little 
bit high concentration of selenium can affect the human 
health such as loosing hair and nails, irritation of skin, eye, 
etc. [1-3]. The outcome of selenium is affected by numerous 
physical, chemical and biological factors, as these factors are 
related with the modifications in its oxidation state. It occurs 
naturally in four different oxidation states, i.e. −2, 0, +4, and 
+6. The different chemical forms of selenium can impact on 
its solubility and availability to organisms. Selenate is the 
most oxidized form among selenium compounds. It is less 
toxic and highly soluble in water [1-5]. Sodium selenate can 
be useful for the prevention and treatment of various ailments 
such as Alzheimer’s disease, diabetes, etc. [6-8]. It is also 
used in the glass industry [9], an ingredient in some 
insecticides (against mites, aphids, and mealybugs) and some 
fungicides [10, 11]. Sodium selenate can be used with 
vitamin E in the prevention of a many nutritional deficiency 
diseases. But, at high concentration, it causes cancers, 
deformation of hair and nails, giddiness, depression and 
nervousness [1]. Selenium methionine is a naturally 
occurring amino acid and is also the major nutritional source 
of selenium for the human body. After absorption in the 
body, inorganic forms of selenium undergo reductive 
metabolism giving H2Se responsible for the production of 
selenoproteins [12]. Therefore, sodium selenate was 
considered as one of the component in a novel proprietary 
herbomineral formulation for the source of selenium ion. 
This herbomineral formulation is designed as nutraceutical 
supplement, and can be used for the prevention and treatment 
of various human disorders. 
The human body can discharge the electromagnetic waves 
in the form of bio-photons that surrounds the body. This 
electromagnetic energy is generated from the continuous 
movement of the electrically charged particles (ions, cells, 
etc.) inside the body. This is collectively known as Biofield. 
Biofield Energy Healing practitioners have the ability to 
harness the energy from the environment or the “universal 
energy field” and can transmit into any living or nonliving 
object(s) around the earth. The process, where the objects 
receive the Biofield Energy Treatment and respond into 
useful way is called as Biofield Energy Healing [13-15]. 
Biofield (Putative Energy Fields) based Energy Therapies are 
used worldwide to promote health and healing. The National 
Center of Complementary and Integrative Health (NCCIH) 
has recognized and accepted Biofield Energy Healing as a 
Complementary and Alternative Medicine (CAM) health care 
approach in addition to other therapies, medicines and 
practices such as natural products, deep breathing, yoga, Tai 
Chi, Qi Gong, chiropractic/osteopathic manipulation, 
meditation, massage, special diets, homeopathy, progressive 
relaxation, guided imagery, acupressure, acupuncture, 
relaxation techniques, hypnotherapy, healing touch, 
movement therapy, pilates, rolfing structural integration, 
mindfulness, Ayurvedic medicine, traditional Chinese herbs 
and medicines, naturopathy, essential oils, aromatherapy, 
Reiki, cranial sacral therapy and applied prayer (as is 
common in all religions, like Christianity, Hinduism, 
Buddhism and Judaism) [16]. From the study on the various 
fields include materials science [17, 18], organic compounds 
[19-21], nutraceuticals [22, 23], pharmaceuticals [24, 25], 
microbiology [26-28], agricultural [29, 30], biotechnology 
[31-33], genetics [34, 35], it has been proven that Biofield 
Energy Healing (also known as The Trivedi Effect®) has the 
astounding capability for alteration of the characteristic 
properties of the several non-living materials and living 
organisms. From the scientific literature, it has been found 
that the bioavailability of inorganic selenium is lower than 
the organic forms of selenium such as selenium methionine. 
But, selenium methionine is easily oxidized to methionine 
selenoxide, which is poorly absorbed from the gut of the 
human body [12]. The physicochemical properties such as 
particle size, crystalline structure, crystallite size, surface 
area, etc. of a drug play an important role in bioavailability, 
as these factors have direct influence on the absorption 
characteristic and stability of the drug [36]. The particle size, 
specific surface area, crystalline nature, chemical and thermal 
behavior of an atom/ion might be altered by the Biofield 
Energy Healing Treatment (The Trivedi Effect®) through the 
possible mediation of neutrinos [37]. Literature mentioned 
that powder X-ray diffraction (PXRD), particle size 
distribution analysis (PSD), Fourier transform infrared (FT-
IR) spectrometry, ultraviolet-visible (UV-vis) spectroscopy, 
thermogravimetric analysis (TGA), and differential scanning 
calorimetry (DSC) analysis play an vital role for solving 
various problems encountered in industries for the 
pharmaceutical/nutraceutical formulation and developments 
[38]. Hence, the objective of the current study was to 
evaluate the effect of the Biofield Energy Healing Treatment 
on the physicochemical, spectral, and thermal properties of 
sodium selenate using various analytical techniques include 
PXRD, PSD, FT-IR spectrometry, UV-vis spectroscopy, 
TGA, and DSC. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Sodium selenate was procured from Alfa Aesar, USA. All 
other chemicals used in the experiment were of analytical 
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grade available in India.  
2.2. Energy of Consciousness Healing Treatment Strategies 
Sodium selenate was one of the components of the new 
proprietary herbomineral formulation, developed by our 
research team and it was used per se as the test compound for 
the current study. The test compound was divided into two 
parts, one part of the test compound did not receive any sort 
of treatment and was defined as the untreated or control 
sodium selenate sample. The second part of the test 
compound was treated with The Trivedi Effect® - Energy of 
Consciousness Healing Treatment (Biofield Energy 
Treatment) by a group of seven renowned Biofield Energy 
Healers remotely and was denoted as Biofield Energy 
Treated or The Trivedi Effect® sample. All seven Biofield 
Energy Healers were remotely located in the U.S.A., while 
the test compound was located in the research laboratory of 
GVK Biosciences Pvt. Ltd., Hyderabad, India. This Biofield 
Energy Treatment was provided for 5 minutes through 
Healer’s Unique Energy Transmission process remotely to 
the test compound under the laboratory conditions. None of 
the Biofield Energy Healers in this study visited the 
laboratory in person, nor had any contact with the 
compounds. Similarly, the control compound was subjected 
to “sham” healers for 5 minutes, under the same laboratory 
conditions. The sham healer did not have any knowledge 
about The Trivedi Effect® - Energy of Consciousness Healing 
Treatment. After that, the treated and untreated samples were 
kept in similar sealed conditions and characterized 
thoroughly by PXRD, PSD, FT-IR, UV-visible spectroscopy, 
TGA, and DSC analysis.  
2.3. Characterization 
2.3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The XRD analysis was accomplished on PANalytical 
X’Pert Pro powder X-ray diffractometer system. The X-ray 
of wavelength 1.54056 Å was used. The data was collected in 
the form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity 
counts, d value (Å), relative intensity (%), full width half 
maximum (FWHM) (θ°). From the XRD results, the 
crystallite size (G) was calculated using X’Pert data collector 
and X’Pert high score plus processing software. The 
crystallite size (G) was calculated from the Scherrer equation 
[39, 40]. The method was based on the width of the 
diffraction patterns obtained in the X-ray reflected the 
crystalline region. The crystallite size (G) was calculated by 
using the following equation 1: 
G = kλ/(bCosθ)                           (1) 
Where, k is the equipment constant (0.5), λ is the X-ray 
wavelength (0.154 nm); b in radians is the full-width at half 
of the peaks and θ the corresponding Bragg angle. 
Percent change in crystallite size (G) was calculated using 
following equation 2: 
%	change	in	crystallite	size	 =
		
	
× 100  (2) 
Where, GControl and GTreated are the crystallite size of the 
control and Biofield Energy Treated samples, respectively. 
A total of ~500 mg of the control and treated samples 
individually were used for the analysis and prepared by back 
loading technique using the sample preparation kit. The 
sample was spread on the holder ring in sufficient quantity to 
fill the ring cavity. It was then pressed down using powder 
press block and scrap the powder that was in surplus using a 
glass slide to get densely packed specimen. Consequently, the 
bottom plate was placed onto the holder ring and clamp in 
position. The sample holder was then removed from the 
sample preparation table by turning it upside down. A 
smooth surface of sample was obtained to ensure optimum 
results. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with a 
detection range between 0.01 µm to 3000 µm. The sample 
unit was filled with dispersant medium and operated the 
stirrer at 2500 rpm. Alignment of the optics was done and 
taken the background measurement. After the background 
measurement, the sample was added into the sample unit 
with constant monitoring the obscuration and stopped the 
addition of sample, when the obscuration reached in between 
15% and 20%. When the obscuration was stable, the 
measurement was taken twice and the average was taken of 
two measurements. The average histogram of the two 
measurements was recorded. Along with histogram, the data 
was presented in Table format which include particle size 
(µm). Also, the values for particle size (µm) for at below 
10% level (d10), 50% level (d50), and 90% level (d90) were 
calculated from the histogram and the calculations such as 
surface area (m2/g) were done by using software Mastersizer 
2000. 
Percent change in particle size (d) for at below 10% level 
(d10), 50% level (d50), and 90% level (d90) was calculated 
using following equation 3: 
%	change	in	particle	size =
##
#
× 100   (3) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
of the control and Biofield Energy Treated samples, 
respectively. 
Percent change in surface area (S) was calculated using 
following equation 4: 
%	change	in	surface	area =
&	&	
&	
× 100   (4) 
Where, SControl and STreated are the surface area of the 
control and Biofield Energy Treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of sodium selenate was performed on 
Spectrum two (Perkin Elmer, USA) Fourier transform 
infrared spectrometer with the frequency array of 400-4000 
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cm-1 by using pressed KBr disk technique. 
2.3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-Vis spectral analysis was carried out using 
Shimadzu UV-2450 with UV Probe, Japan. The spectrum 
was recorded using 1 cm quartz cell that has a slit width of 
1.0 nm. The wavelength range chosen for recording the 
spectra were 190-800 nm. The absorbance spectra (in the 
range of 0.2 to 0.9) and wavelength of maximum absorbance 
(λmax) were recorded. 
2.3.5. Thermal Gravimetric Analysis (TGA) 
TGA analysis was performed using Instrument TGA Q50 
(TA Instruments, USA) at a heating rate of 10°C/min from 
room temperature i.e. 30°C to 900°C under nitrogen the 
atmosphere (sample mass ~ 15 mg on the platinum pan). In 
TGA, the weight loss for each step was recorded in grams as 
well as in percent loss with respect to the initial weight. Also, 
the value of onset, endset, and peak temperature for each step 
were recorded in TGA. Percent change in weight loss (W) 
was calculated using following equation 5: 
%	change	in	weight	loss 
)	)	
)	
 100   (5) 
Where, WControl and WTreated are the weight loss of the 
control and Biofield Energy Treated samples, respectively. 
2.3.6. Differential Scanning Calorimetry (DSC) 
Analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter. ~ 5 mg 
of sample was weighed and sealed in alumina pan and 
equilibrated at 25°C and heated up to 650°C at the heating 
rate of 10°C/min under nitrogen gas as purge atmosphere 
with the flow rate of 50 mL/min. The value for onset, endset, 
peak temperature, peak height (mJ or mW), peak area, and 
change in heat (J/g) for each peak were recorded. Percent 
change in melting point (T) was calculated using following 
equation 6: 
%	change	in	melting	point 
++
+
 100  (6) 
Where, TControl and TTreated are the melting point of the 
control and treated samples, respectively. 
Percent change in the latent heat of fusion (∆H) was 
calculated using following equation 7: 
%	change	in	latent	heat	of	fusion 
∆-.-
.-
 100                                         (7) 
Where, ∆HControl and ∆HTreated are the latent heat of fusion 
of the control and treated samples, respectively. 
3. Results and Discussion 
3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of the both control and treated 
sodium selenate (Figure 1) showed very sharp and intense 
peaks indicating that both these samples were crystalline in 
nature. PXRD data such as Bragg angle (2θ), relative 
intensity (%), full width half maximum (FWHM) (θ°), and 
crystallite size (G) for the control and treated sodium selenate 
are presented in Table 1. The crystallite size was calculated 
by the help of Scherrer equation [39, 40].  
 
Figure 1. PXRD diffractograms of the control and Biofield Energy Treated sodium selenate. 
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Table 1. PXRD data for the control and Biofield Energy Treated sodium selenate. 
Entry 
No. 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated  Control Treated  Control Treated  Control Treated  % change* 
1 18.38 18.39 100.00 100.00 0.0836 0.0836 53.34 53.34 0.00 
2 22.49 22.49 19.97 19.34 0.1171 0.1171 38.33 38.33 0.00 
3 27.25 27.25 48.04 46.92 0.1338 0.1004 33.85 45.12 33.27 
4 28.36 28.37 27.40 31.83 0.1004 0.1004 45.23 45.23 0.00 
5 31.00 31.01 61.79 71.62 0.1004 0.1171 45.50 39.02 -14.26 
6 32.61 32.61 73.46 72.52 0.0669 0.1020 68.57 44.97 -34.41 
7 37.21 37.22 21.68 20.75 0.1506 0.1632 30.85 28.47 -7.72 
8 47.37 47.36 30.74 22.40 0.0816 0.1020 58.93 47.14 -20.00 
9 48.81 48.81 10.73 10.91 0.1020 0.1171 47.41 41.30 -12.89 
10 52.96 52.97 27.88 30.70 0.1428 0.1428 34.46 34.46 0.00 
11 57.17 57.17 12.74 12.58 0.1224 0.1224 40.98 40.98 0.00 
12 Average crystallite size* 45.22 41.67 -7.85 
FWHM: Full width half maximum, *denotes the percentage change in the crystallite size of Biofield Energy Treated sample with respect to the control sample. 
The diffractograms showed the notable changes of the 
crystallite size of the treated sodium selenate compared with 
the control sample. From Table 1 (entry 1), the most intense 
peaks for the control and treated samples were found at 2θ 
equal to 18.38° and 18.89, respectively. The crystallite size 
of the Biofield Energy Treated sodium selenate at 2θ equal to 
nearly 27.3° (Table 1, entry 3) was significantly increased by 
33.27% with respect to the control sample. In contrast, at 
position 2θ equal to nearly 31.0°, 32.6°, 37.2°, 47.4°, and 
48.8° (Table 1, entry 5-9), and the crystallite size values of 
the Biofield Energy Treated samples were markedly 
decreased in the range of 7.72% to 34.41% in comparison to 
the control sample. But, the crystallite size of the control and 
Biofield Energy Treated sodium selenate at 2θ equal to 
nearly 18.4°, 22.5°, 28.4°, 52.9, and 57.2° (Table 1, entry 1, 
2, 4, 10, and 11) were the same value. Overall, the average 
crystallite size of the Biofield Energy Treated sodium 
selenate was significantly decreased by 7.85% compared 
with the control sample. Beside these, other XRD parameters 
such as relative intensities of the PXRD peaks in the Biofield 
Energy Treated sodium selenate were significantly changed 
compared to the control sample. It has been reported that 
XRD relative intensity of each diffraction face on crystalline 
compound changes according to the crystal morphology [41]. 
Literature demonstrated that alterations in the XRD pattern 
provide the proof of polymorphic transitions [42-44]. Hence, 
changes in the crystallite size and relative intensities of XRD 
peaks revealed that the crystal morphology of the Biofield 
Energy Treated sample was modified from the control 
sample. Thus, it is anticipated that the change in the crystal 
morphology of the sodium selenate was due to the energy 
transferred through Biofield Energy Healing (The Trivedi 
Effect®) and this probably introduced a new polymorphic 
form of sodium selenate. Crystal habit, size and even 
polymorphic form of a drug have an important effect on drug 
solubility, dissolution, and bioavailability. Numerous 
examples in the scientific literature establish the impacts of 
alteration in crystal morphology on in vitro dissolution rate, 
with prospective for improving bioavailability [45]. Thus, it 
is inferred that The Trivedi Effect® - Energy of 
Consciousness Healing Treatment might help for improving 
the bioavailability of sodium selenate. 
3.2. Particle Size Distribution (PSD) Analysis 
Particle size (d10, d50, and d90) and surface area of both the 
control and Biofield Energy Treated sodium selenate were 
explored and the results are presented in Table 2. The particle 
size values of the control sodium selenate at d10, d50, and d90 
were 5.09 µm, 24.76 µm, and 95.13 µm, respectively. The 
particle size values at d10, d50, and d90 of the Biofield Energy 
Treated sodium selenate were 4.85 µm, 22.68 µm, and 64.37 
µm, respectively. Thus, the particle size values at d10, d50, and 
d90 of the Biofield Energy Treated sodium selenate were 
significantly reduced by 4.72%, 8.40%, and 32.33%, 
respectively with respect to the control sample. The surface 
area analysis demonstrated that the surface area of the 
Biofield Energy Treated sodium selenate (0.51 m2/g) was 
significantly increased by 6.25% compared with the control 
sample (0.48 m2/g). 
Table 2. Particle size data (d10, d50, and d90) and surface area of the control 
and Biofield Energy Treated sodium selenate. 
Parameter d10 (µm) d50 (µm) d90 (µm) 
Surface area 
(m2/g) 
Control 5.09 24.76 95.13 0.48 
Biofield Treated 4.85 22.68 64.37 0.51 
Percent change* (%)  -4.72 -8.40 -32.33 6.25 
*denotes the percentage change in the particle size data (d10, d50, and d90) and 
surface area of Biofield Energy Treated sample with respect to the control 
sample. 
The particle size, shape and surface area of the compound 
plays a vital role in the solubility, absorption, dissolution and 
bioavailability of the pharmaceuticals [36, 46, 47]. Reduction 
in particle size and higher surface area enhance the solubility 
of the solid particles as well as increase the dissolution rate 
and bioavailability [48]. Thus, it is predicted that The Trivedi 
Effect® - Energy of Consciousness Healing Treatment 
sodium selenate might be absorbed in faster rate from the gut 
and thus, can offer more bioavailability than the untreated 
sample.  
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of both the control and Biofield Energy 
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Treated samples of sodium selenate are exhibited in Figure 2. 
The scientific literature reported that the water molecules 
which are incorporated into the lattice structure of the 
crystalline inorganic compounds harvest the characteristic 
absorption bands in the 3800-3200 cm-1 and 1700-1600 cm-1 
regions due to the O-H stretching and bending for the water 
molecules, respectively [49]. The control IR spectrum 
displayed the O-H stretching and bending absorption bands at 
3441, 1780, and 1706 cm-1, respectively. In addition, peaks 
for the O-H stretching and bending of the water molecules in 
the Biofield Energy Treated sample were found at 3436, 
1775, and 1628 cm-1. The fingerprint region of the Biofield 
Energy Treated and control samples was remained 
unchanged. From the literature, it has been found that M=O 
(metal-oxide) stretching absorption band for inorganic 
materials was found in the 1010-850 cm-1 region [49]. A 
sharp and strong absorption bands at 886 cm-1 due to the 
Se=O stretching were found in the spectrum of the control 
sample, while Biofield Energy Treated sample exhibited this 
peak at 887 cm-1. The analysis indicated that structure of the 
Biofield Energy Treated sodium selenate was remained same 
with respect to the control sample. 
 
Figure 2. FT-IR spectra of the control and Biofield Energy Treated sodium selenate. 
3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of both the control and Biofield 
Energy Treated sodium selenate are shown in Figure 3. The 
wavelength of the maximum absorbance (λmax) of the control 
and treated sodium selenate were at 204.6 and 204.9 nm, 
respectively and there was a minor shift of absorbance 
maxima from 2.5675 in control sample to 2.5658 in the 
treated sample. However, the λmax of the treated sample 
remained unchanged compared with the control sample. The 
UV absorbance happens due to the different type of energy 
transitions from the singlet to the singlet excited state such as 
σ → σ*, n → π*, and π → π*. These type of electronic 
transitions occur when the difference in energy between the 
lowest unoccupied molecular orbital (LUMO) and the 
highest occupied molecular orbital (HOMO) is significantly 
greater than the activation energy of the compound [50]. As. 
there was no change in the λmax of the treated sample as 
compared to the control, it is anticipated that the structural 
configuration or activation energy of sodium selenate 
remained unchanged due to The Trivedi Effect® - Energy of 
Consciousness Healing Treatment.  
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Figure 3. UV-vis spectra of the control and Biofield Energy Treated sodium selenate. 
3.5. Thermal Gravimetric Analysis (TGA) 
The thermal stability of a solid compound plays an 
important role in the quality, efficacy, and safety in a drug 
formulation during the manufacturing process, shipment, 
storage, and handling [51]. Hence, TGA and DSC analysis 
were used to examine the thermal stability of both the control 
and treated sodium selenate. The TGA thermograms of both 
the control and treated samples and their thermal analysis 
data are shown in Figure 4. The TGA analysis showed one 
steps of thermal degradation of sodium selenate. 
 
Figure 4. TGA thermograms of the control and Biofield Energy Treated sodium selenate. 
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The TGA thermogram of the control sample exhibited 
4.43% weight loss from 28.77°C to 895.95°C. Consequently, 
the TGA thermogram of the Biofield Energy Treated sample 
showed 4.18% weight loss from 30.36°C to 895.49°C. The 
weight loss of the treated sample was significantly reduced 
by 5.64% compared with the control sample. Thus, it is 
assumed that The Trivedi Effect® - Energy of Consciousness 
Healing Treatment might improve the thermal stability of 
sodium selenate. 
3.6. Differential Scanning Calorimetry (DSC) Analysis 
The DSC thermograms of both the control and Biofield 
Energy Treated sodium selenate are shown in Figure 5 and 
their DSC data are depicted in Table 3. The DSC thermogram 
of the control sample showed the presence of a sharp 
endothermic inflection at 94.97°C which was due to 
evaporation of the bound water and the latent heat of 
vaporization (∆Hvaporization) was 4.39 J/g. Consequently, the 
Biofield Energy Treated sodium selenate showed this 
endothermic peak at 94.63°C along with a latent heat of 
vaporization (∆Hvaporization) of 4.70 J/g. This suggested that 
the temperature of the evaporation of the bound water in the 
Biofield Energy Treated sample was slightly (0.21%) 
decreased, whereas the ∆Hvaporization was increased 
significantly by 7.06% compared to the control sample.  
 
Figure 5. DSC thermograms of the control and Biofield Energy Treated sodium selenate. 
Table 3. Comparison of DSC data between the control and Biofield Energy Treated sodium selenate. 
Sample 
Onset vaporization 
temperature (Tonset) °C 
Peak vaporization 
temperature (Tpeak) °C 
Endset vaporization 
temperature (Tendset) °C 
Latent heat of vaporization 
(∆Hvaporization) J/g 
Control 89.13 94.97 100.53 4.39 
Biofield Energy Treated 88.94 94.63 100.53 4.70 
% Change* -0.21 -0.36 0.00 7.06 
Tonset: Onset vaporization temperature, Tpeak: Peak vaporization temperature, Tendset: Endset vaporization temperature, ∆Hvaporization: Latent heat of evaporation, 
*denotes the percentage change of Biofield Energy Treated sample with respect to the control sample. 
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4. Conclusions 
The current analysis revealed that The Trivedi Effect® - 
Energy of Consciousness Healing Treatment (Biofield Energy 
Healing Treatment) displayed the significant impact on the 
physicochemical and thermal properties of sodium selenate. 
The PXRD analysis showed the remarkable alteration of the 
crystallite size of the treated sample from -34.41% to 33.27% 
compared with the control sample. Overall, the average 
crystallite size of the treated sodium selenate was significantly 
decreased by 7.85% compared with the control sample. This 
result indicated that the crystal morphology of the treated 
sodium selenate was changed from the control sample and The 
Trivedi Effect® - Biofield Energy Healing might lead to a new 
polymorphic form of sodium selenate. The particle size of the 
Biofield Energy Treated sample at d10, d50, and d90 values were 
significantly decreased by 4.72%, 8.40%, and 32.33%, 
respectively compared with the control sample. Similarly, the 
surface area of the treated sample was significantly increased 
by 6.25% compared with the control sample. TGA analysis 
revealed that the total weight loss of the Biofield Energy 
Treated sample was reduced by 4.93% compared with the 
control sample. The DSC analysis revealed that the treated 
sample (95.10°C) had higher vaporization temperature than the 
control sample (94.80°C). The latent heat of vaporization was 
increased significantly in the Biofield Energy Treated sample 
by 7.06% compared to the control sample. Briefly, the Biofield 
Energy Treated sodium selenate might be a new polymorphic 
form (i.e. enantiotropic) of sodium selenate having reduced 
crystallite and particle size and increased surface area. Thus, 
The Trivedi Effect® treated sodium selenate could be more 
soluble, bioavailable, and thermally stable than the control 
sample. Hence, The Trivedi Effect® treated sodium selenate 
would be very useful to design better nutraceutical and/or 
pharmaceutical formulations that might offer better therapeutic 
response against various diseases such as diabetes mellitus, 
allergies, and septic shock; stress-related disorders like sleep 
disorder, insomnia, anxiety, depression, Attention Deficit 
Disorder (ADD), Attention Deficit Hyperactive Disorder 
(ADHD), mental restlessness (mind chattering), brain frog, 
low libido, impotency, lack of motivation, mood swings, fear 
of the future, confusion, migraines, headaches, forgetfulness, 
overwhelm, loneliness, worthlessness, indecisiveness, 
frustration, irritability, chronic fatigue, obsessive/compulsive 
behavior and panic attacks; inflammatory diseases and 
immunological disorders like Lupus, Systemic Lupus 
Erythematosus, Hashimoto Thyroiditis, Type 1 Diabetes, 
Asthma, Chronic peptic ulcers, Tuberculosis, Hepatitis, 
Chronic active hepatitis, Celiac Disease (gluten-sensitive 
enteropathy), Addison Disease, Crohn's disease, Graves’ 
Disease, Pernicious and Aplastic Anemia, Sjogren Syndrome, 
Irritable Bowel Syndrome (IBS), Multiple Sclerosis, 
Rheumatoid arthritis, Chronic periodontitis, Ulcerative colitis, 
Chronic sinusitis, Myasthenia Gravis, Atherosclerosis, 
Vasculitis, Dermatitis, Diverticulitis, Rheumatoid Arthritis, 
Reactive Arthritis, Alopecia Areata, Psoriasis, Scleroderma, 
Fibromyalgia, Chronic Fatigue Syndrome and Vitiligo; aging-
related diseases like cardiovascular disease, arthritis, cancer, 
Alzheimer’s disease, dementia, cataracts, osteoporosis, 
diabetes, hypertension, glaucoma, hearing loss, Parkinson’s 
Disease, Huntington’s Disease, Prion Disease, Motor Neurone 
Disease, Spinocerebellar Ataxia, Spinal muscular atrophy, 
Amyotrophic lateral sclerosis, Friedreich’s Ataxia, Lewy Body 
Disease, chronic infections and much more. 
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